Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-targeting Pyruvate Dehydrogenase Kinase Inhibitors

Podobne zapisy

• Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex
  od: Kato, Masato, i wsp.
  Wydane: (2005)
• Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket
  od: Tso, Shih-Chia, i wsp.
  Wydane: (2014)
• Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice
  od: Wu, Cheng-Yang, i wsp.
  Wydane: (2018)
• Pyruvate Dehydrogenase Kinase-4 Structures Reveal a Metastable Open Conformation Fostering Robust Core-free Basal Activity
  od: Wynn, R. Max, i wsp.
  Wydane: (2008)
• Structural Basis for Inactivation of the Human Pyruvate Dehydrogenase Complex by Phosphorylation: Role of Disordered Phosphorylation Loops
  od: Kato, Masato, i wsp.
  Wydane: (2008)